Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03827850
Title FGFR Inhibitor in FGFR Dysregulated Cancer (FIND)
Acronym FIND
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Lung Cancer Group Cologne
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU

Additional content available in CKB BOOST